 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$13.01 |
$13.13 |
$12.15 |
$12.36 |
4.50M | | 04/15/2024 |
$12.35 |
$12.53 |
$11.66 |
$11.89 |
6.39M | | 04/16/2024 |
$11.79 |
$12.14 |
$11.53 |
$11.92 |
5.40M | | 04/17/2024 |
$11.96 |
$12.12 |
$11.65 |
$11.80 |
3.14M | | 04/18/2024 |
$11.68 |
$11.94 |
$11.47 |
$11.72 |
3.70M |
|
|
| Iovance Biotherapeutics is a clinical-stage biopharmaceutical company developing a transformational approach to cure cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells in each patient. Tumor infiltrating lymphocyte therapy is an autologous, polyclonal cell therapy platform technology that was developed by the National Cancer Institute which conducted initial clinical trials of this therapy in diseases such as metastatic melanoma and cervical cancer. Co.'s primary product candidates include lifileucel for metastatic melanoma and metastatic cervical cancer, as well as LN-145 for metastatic non-small cell lung cancer. | |
|
Iovance Biotherapeutics (IOVA) has the following price history information. Looking back at IOVA historical stock prices for the last five trading days, on April 12, 2024, IOVA opened at $13.01, traded as high as $13.13 and as low as $12.15, and closed at $12.36. Trading volume was a total of 4.50M shares. On April 15, 2024, IOVA opened at $12.35, traded as high as $12.53 and as low as $11.66, and closed at $11.89. Trading volume was a total of 6.39M shares. On April 16, 2024, IOVA opened at $11.79, traded as high as $12.14 and as low as $11.53, and closed at $11.92. Trading volume was a total of 5.40M shares. On April 17, 2024, IOVA opened at $11.96, traded as high as $12.12 and as low as $11.65, and closed at $11.80. Trading volume was a total of 3.14M shares. On April 18, 2024, IOVA opened at $11.68, traded as high as $11.94 and as low as $11.47, and closed at $11.72. Trading volume was a total of 3.70M shares.
IOVA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Iovance Biotherapeutics shares, starting with a $10,000 purchase of IOVA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$8.70 |
|
| End price/share: |
$11.72 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
34.71% |
|
| Average Annual Total Return: |
3.03% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,477.26 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/12/2024 | $12.36 | | 04/15/2024 | $11.89 | | 04/16/2024 | $11.92 | | 04/17/2024 | $11.80 | | 04/18/2024 | $11.72 |
|
|
Free IOVA Email Alerts:
